The Carlyle Group LP (Corporate Private Equity) sold $336M worth of shares in Pharmaceutical Product Development, Inc. in September 2020

Oct 08, 2020
Insider Transactions
Background Information
The Carlyle Group LP (Corporate Private Equity) focuses either on a particular geography (Asia, Europe, Japan, Middle East and North Africa (MENA), South America, Sub-Saharan Africa or the United States) or a particular industry, such as financial services. The firm invests in aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, real estate, technology & business services, telecommunications & media, and transportation. They provide capital for buyouts and growth capital requirements.
PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.